The important activity for fund was in 2012. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 1 - 5 millions dollars are the general things for fund.
Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Xenikos
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are OostNL, Innovation & Investment Fund Gelderland. In the next rounds fund is usually obtained by RA Capital Management, Medicxi Ventures, Agentschap NL.
|Accelerant Capital Partners||New York, New York, United States|
|Aquarius Equity Partners||England, Manchester, United Kingdom|
|Biotech Fund Flanders||Antwerp, Antwerpen, Belgium|
|Chang Development||Beijing, Changping, China|
|Crypto Dorm Fund||-|
|Long Ridge Equity Partners||New York, New York, United States|
|Milkbox Partners||New York, New York, United States|
|PJC||Boston, Massachusetts, United States|
|Qinxing Technology||China, Guangdong Province, Huizhou|
|$47M||08 Sep 2021||Nijmegen, Gelderland, Netherlands|
|$4M||19 Jun 2012||Nijmegen, Gelderland, Netherlands|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.